Table of Contents

- E Ipp
Impaired glucose tolerance: the irrepressible alpha-cell?
Diabetes Care May 2000 23:569-570; doi:10.2337/diacare.23.5.569
- Full Text (PDF)
- A Schiffrin
Nighttime continuous subcutaneous insulin infusion revisited: a strategy for improving insulin delivery.
Diabetes Care May 2000 23:571-573; doi:10.2337/diacare.23.5.571
- Full Text (PDF)
- J P Palmer
Therapeutic importance of subsets of type 2 diabetes?
Diabetes Care May 2000 23:574-575; doi:10.2337/diacare.23.5.574
- Full Text (PDF)
- J Buse
Insulin glargine (HOE901): first responsibilities: understanding the data and ensuring safety.
Diabetes Care May 2000 23:576-578; doi:10.2337/diacare.23.5.576
- Full Text (PDF)
Select this article
- F R Kaufman,
- M Halvorson,
- C Kim,
- and P Pitukcheewanont
Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes.
Diabetes Care May 2000 23:579-582; doi:10.2337/diacare.23.5.579
- Abstract
- Full Text (PDF)
Select this article
- P Raskin,
- R A Guthrie,
- L Leiter,
- A Riis,
- and L Jovanovic
Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes.
Diabetes Care May 2000 23:583-588; doi:10.2337/diacare.23.5.583
- Abstract
- Full Text (PDF)
Select this article
- H Li,
- B Isomaa,
- M R Taskinen,
- L Groop,
- and T Tuomi
Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes.
Diabetes Care May 2000 23:589-594; doi:10.2337/diacare.23.5.589
- Abstract
- Full Text (PDF)
Select this article
- W C Hsueh,
- B D Mitchell,
- R Aburomia,
- T Pollin,
- H Sakul,
- M Gelder Ehm,
- B K Michelsen,
- M J Wagner,
- P L St Jean,
- W C Knowler,
- D K Burns,
- C J Bell,
- and A R Shuldiner
Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study.
Diabetes Care May 2000 23:595-601; doi:10.2337/diacare.23.5.595
- Abstract
- Full Text (PDF)
Select this article
- A Biderman,
- I Rosenblatt,
- S Rosen,
- L M Zangwill,
- R Shalev,
- M Friger,
- and S Weitzman
Sex differentials in predictors of mortality for patients with adult-onset diabetes: a population-based follow-up study in Beer-Sheva, Israel.
Diabetes Care May 2000 23:602-605; doi:10.2337/diacare.23.5.602
- Abstract
- Full Text (PDF)
Select this article
- H Pham,
- D G Armstrong,
- C Harvey,
- L B Harkless,
- J M Giurini,
- and A Veves
Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.
Diabetes Care May 2000 23:606-611; doi:10.2337/diacare.23.5.606
- Abstract
- Full Text (PDF)
Select this article
- C Laberge-Nadeau,
- G Dionne,
- J M Ekoé,
- P Hamet,
- D Desjardins,
- S Messier,
- and U Maag
Impact of diabetes on crash risks of truck-permit holders and commercial drivers.
Diabetes Care May 2000 23:612-617; doi:10.2337/diacare.23.5.612
- Abstract
- Full Text (PDF)
Select this article
- P J Lustman,
- K E Freedland,
- L S Griffith,
- and R E Clouse
Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial.
Diabetes Care May 2000 23:618-623; doi:10.2337/diacare.23.5.618
- Abstract
- Full Text (PDF)
Select this article
- A Festa,
- R D'Agostino, Jr,
- C N Hales,
- L Mykkänen,
- and S M Haffner
Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects.
Diabetes Care May 2000 23:624-628; doi:10.2337/diacare.23.5.624
- Abstract
- Full Text (PDF)
Select this article
- M M Janssen,
- F J Snoek,
- N Masurel,
- R P Hoogma,
- W L Devillé,
- C Popp-Snijders,
- and R J Heine
Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction.
Diabetes Care May 2000 23:629-633; doi:10.2337/diacare.23.5.629
- Abstract
- Full Text (PDF)
Select this article
- C H van Schie,
- A Whalley,
- L Vileikyte,
- T Wignall,
- S Hollis,
- and A J Boulton
Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial.
Diabetes Care May 2000 23:634-638; doi:10.2337/diacare.23.5.634
- Abstract
- Full Text (PDF)
Select this article
- R E Ratner,
- I B Hirsch,
- J L Neifing,
- S K Garg,
- T E Mecca,
- and C A Wilson
Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.
Diabetes Care May 2000 23:639-643; doi:10.2337/diacare.23.5.639
- Abstract
- Full Text (PDF)
Select this article
- L Heinemann,
- R Linkeschova,
- K Rave,
- B Hompesch,
- M Sedlak,
- and T Heise
Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.
Diabetes Care May 2000 23:644-649; doi:10.2337/diacare.23.5.644
- Abstract
- Full Text (PDF)
Select this article
- H Larsson and
- B Ahrén
Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.
Diabetes Care May 2000 23:650-657; doi:10.2337/diacare.23.5.650
- Abstract
- Full Text (PDF)
Select this article
- R Marfella,
- F Nappo,
- L De Angelis,
- G Paolisso,
- M R Tagliamonte,
- and D Giugliano
Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients.
Diabetes Care May 2000 23:658-663; doi:10.2337/diacare.23.5.658
- Abstract
- Full Text (PDF)
Select this article
- E Korpinen,
- A M Teppo,
- L Hukkanen,
- H K Akerblom,
- C Grönhagen-Riska,
- and O Vaarala
Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes.
Diabetes Care May 2000 23:664-668; doi:10.2337/diacare.23.5.664
- Abstract
- Full Text (PDF)
Select this article
- J B Meigs,
- J M Ordovas,
- L A Cupples,
- D E Singer,
- D M Nathan,
- E J Schaefer,
- and P W Wilson
Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study.
Diabetes Care May 2000 23:669-674; doi:10.2337/diacare.23.5.669
- Abstract
- Full Text (PDF)
Select this article
- C B Juhl,
- N Pørksen,
- M Hollingdal,
- J Sturis,
- S Pincus,
- J D Veldhuis,
- A Dejgaard,
- and O Schmitz
Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency.
Diabetes Care May 2000 23:675-681; doi:10.2337/diacare.23.5.675
- Abstract
- Full Text (PDF)
- C Mensing,
- J Boucher,
- M Cypress,
- K Weinger,
- K Mulcahy,
- P Barta,
- G Hosey,
- W Kopher,
- A Lasichak,
- B Lamb,
- M Mangan,
- J Norman,
- J Tanja,
- L Yauk,
- K Wisdom,
- and C Adams
National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs.
Diabetes Care May 2000 23:682-689; doi:10.2337/diacare.23.5.682
- Full Text (PDF)
- Z T Bloomgarden
American Diabetes Association annual meeting, 1999: dyslipidemia, endothelial dysfunction, and glycosylation.
Diabetes Care May 2000 23:690-698; doi:10.2337/diacare.23.5.690
- Full Text (PDF)
- J A Kiayias,
- E D Vlachou,
- and E Lakka-Papadodima
Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy.
Diabetes Care May 2000 23:699; doi:10.2337/diacare.23.5.699b
- Full Text (PDF)
- K Spengos,
- J C Wöhrle,
- J Binder,
- A Schwartz,
- and M Hennerici
Bilateral diabetic infarction of the anterior tibial muscle.
Diabetes Care May 2000 23:699-701; doi:10.2337/diacare.23.5.699a
- Full Text (PDF)
- P Marchetti,
- F Dotta,
- Z Ling,
- R Lupi,
- S Del Guerra,
- C Santangelo,
- M Realacci,
- L Marselli,
- U Di Mario,
- and R Navalesi
Function of pancreatic islets isolated from a type 1 diabetic patient.
Diabetes Care May 2000 23:701-703; doi:10.2337/diacare.23.5.701
- Full Text (PDF)
- M W Mansfield,
- H P Kohler,
- R A Ariëns,
- L J McCormack,
- and P J Grant
Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives.
Diabetes Care May 2000 23:703-705; doi:10.2337/diacare.23.5.703
- Full Text (PDF)
- H Yasuda,
- A Hirai,
- M Joko,
- M Terada,
- T Kawabata,
- K Maeda,
- M Haneda,
- A Kashiwagi,
- T Maeda,
- and R Kikkawa
Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients.
Diabetes Care May 2000 23:705; doi:10.2337/diacare.23.5.705b
- Full Text (PDF)
- Y Ohyama,
- T Utsugi,
- T Uchiyama,
- T Hanaoka,
- S Tomono,
- and M Kurabayashi
Prevalence of diabetes in adult patients with Down's syndrome living in a residential home.
Diabetes Care May 2000 23:705-706; doi:10.2337/diacare.23.5.705a
- Full Text (PDF)
- M B Davidson and
- G Lewis
Effect of data management on a central server on HbA1c levels in insulin-requiring patients.
Diabetes Care May 2000 23:706-707; doi:10.2337/diacare.23.5.706
- Full Text (PDF)
- J Y Park,
- Y I Kim,
- C S Choi,
- Y E Chung,
- S W Kim,
- M S Lee,
- S I Lee,
- S K Hong,
- and K U Lee
Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria.
Diabetes Care May 2000 23:707-708; doi:10.2337/diacare.23.5.707
- Full Text (PDF)
- R Suzuki,
- A Shimada,
- K Konishi,
- and T Saruta
Rapid remission of nephrotic-range proteinuria in a case of histologically proven diabetic nephropathy treated with an ACE inhibitor.
Diabetes Care May 2000 23:708-710; doi:10.2337/diacare.23.5.708
- Full Text (PDF)
- Y Tanaka,
- Y Atsumi,
- K Matsuoka,
- T Onuma,
- and R Kawamori
Interesting insulin response to oral glucose load in young Japanese subjects with impaired glucose tolerance.
Diabetes Care May 2000 23:710-712; doi:10.2337/diacare.23.5.710
- Full Text (PDF)
- J S Cheng
An equation for insulin sensitivity index.
Diabetes Care May 2000 23:712; doi:10.2337/diacare.23.5.712b
- Full Text (PDF)
- D Iafusco,
- F Rea,
- F Chiarelli,
- A Mohn,
- and F Prisco
Effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease.
Diabetes Care May 2000 23:712-713; doi:10.2337/diacare.23.5.712a
- Full Text (PDF)
- T Cundy and
- J Baker
Prediction of albumin excretion rate from albumin-to-creatinine ratio.
Diabetes Care May 2000 23:714; doi:10.2337/diacare.23.5.714b
- Full Text (PDF)
- O Vaccaro,
- G Ruffa,
- and G Riccardi
Is there any use for the oral glucose tolerance test?
Diabetes Care May 2000 23:714-715; doi:10.2337/diacare.23.5.714a
- Full Text (PDF)

Diabetes Care

Impaired glucose tolerance: the irrepressible alpha-cell?

Nighttime continuous subcutaneous insulin infusion revisited: a strategy for improving insulin delivery.

Therapeutic importance of subsets of type 2 diabetes?

Insulin glargine (HOE901): first responsibilities: understanding the data and ensuring safety.

Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes.

Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes.

Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes.

Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study.

Sex differentials in predictors of mortality for patients with adult-onset diabetes: a population-based follow-up study in Beer-Sheva, Israel.

Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.

Impact of diabetes on crash risks of truck-permit holders and commercial drivers.

Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial.

Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects.

Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction.

Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial.

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.

Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.

Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients.

Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes.

Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study.

Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency.

National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs.

American Diabetes Association annual meeting, 1999: dyslipidemia, endothelial dysfunction, and glycosylation.

Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy.

Bilateral diabetic infarction of the anterior tibial muscle.

Function of pancreatic islets isolated from a type 1 diabetic patient.

Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives.

Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients.

Prevalence of diabetes in adult patients with Down's syndrome living in a residential home.

Effect of data management on a central server on HbA1c levels in insulin-requiring patients.

Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria.

Rapid remission of nephrotic-range proteinuria in a case of histologically proven diabetic nephropathy treated with an ACE inhibitor.

Interesting insulin response to oral glucose load in young Japanese subjects with impaired glucose tolerance.

An equation for insulin sensitivity index.

Effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease.

Prediction of albumin excretion rate from albumin-to-creatinine ratio.

Is there any use for the oral glucose tolerance test?

This Issue

Current Issue

Issue Highlights